CClinicalTrials.gg
CompletedNCT06753539Updated Feb 13, 2025

Evaluation of the "Grasp Site" After Peeling of Epiretinal Membranes

An interventional study of ILM forceps - membrane grasping in Epiretinal Membrane, sponsored by Prim. Prof. Dr. Oliver Findl, MBA. Completed at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-13.

Sponsored by Prim. Prof. Dr. Oliver Findl, MBA · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled May 2023, registered Dec 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to compare the novel ILM sharkskin forceps with a conventional ILM forceps utilizing iOCT assistance during surgery at this "grasp site". The main questions it aims to answer are:

  1. are there differences in grasp attempts between both forceps
  2. are there differences in Instrument tissue interactions between both forceps
  3. are there differences in postsurgical anatomical and functional outcomes at the grasp site between both forceps.
Read the detailed description

Epiretinal membranes are a disease of the retinal surface, that may affect visual acuity acuity and cause metamorphopsia, occurring in approximately 20% of the population older than 60 years. Using vitrectomy with membrane peeling, postoperative improvement of visual acuity and metamorphopsia may be achieved in a majority of patients. The surgical method has been used for some time, the first report on the surgical method of vitrectomy with membrane peeling dates back to 1978, and since the introduction of intraoperative optical coherence tomography (iOCT), intraoperative iatrogenically induced changes in retinal tissue can be detected and correlated with postoperative changes. Our group has been able to record "stretching" of the retinal tissue using this technique and has also been able to record the rarely occurring subfoveal and extrafoveal elevations of the ellipsoidal zone due to membrane peeling. These changes did not significantly affect postoperative visual acuity in our study population but did affect the development of postoperative microscotomas. Besides "retinal stretching" during surgery, ILM peeling is shown to be another factor with association of new postoperative microscotomas. New postoperative microscotomas developed in some patients without "retinal stretching" and ILM peeling. Apart from these already known iatrogenic changes, the analysis of the "grasp site" at the "starting point" of epiretinal membrane peeling is of great interest, because at this location, grasping of the epiretinal membrane may be difficult especially in case of an adherent ERM and superficial retinal lesions may be induced.

Diaz et al. demonstrated that there are postoperative changes in the "nerve fiber layer" after ILM peeling, but in that study, no recording of instrument/tissue interactions was performed using iOCT.

The aim of this study is to compare the novel ILM sharkskin forceps with a conventional ILM forceps utilizing iOCT assistance during surgery at this "grasp site".

02

Conditions studied

  • Epiretinal Membrane

Browse trials for

03

In context

Epiretinal Membrane

120 studies on the registry are indexed under Epiretinal Membrane; 14 are open to participants now.

This study's enrollment of 58 is above the median of 50 across 73 interventional studies indexed under Epiretinal Membrane.

Browse Epiretinal Membrane studies →

Lead sponsor

Prim. Prof. Dr. Oliver Findl, MBA is the lead sponsor of 38 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Idiopathic ERM
  • Sheduled surgery (vitrectomy with membrane peeling), as defined by vision loss and/or metamorphopsia
  • Age 18 and older
  • Written informed consent for participation in the study

Exclusion criteria

Exclusion Criteria:

  • Macular edema due to other reasons than iERM
  • Pregnancy (pregnancy test will be performed in women of reproductive age)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
58 participants (actual)

Study arms

  • Experimental
    ILM sharkskin forceps

    Patients were operated on using an ILM forceps with a laser-modified microstructure on the branches.

    Device: ILM forceps - membrane grasping

  • Active comparator
    conventional ILM forceps

    Patients were operated on using a conventional ILM forceps with plain surfaces on the branches.

    Device: ILM forceps - membrane grasping

Interventions

  • DeviceILM forceps - membrane grasping

    grasping the epiretinal membrane at the starting location, using pinch peeling, is performed with an ILM forceps.

06

What researchers measure

Primary outcomes

  1. grasp attempts

    number of attemps needed for opening the epiretinal membrane during grasping

    Time frame: during surgery

Secondary outcomes

  1. metamorphopsia

    Presence of metamorphopsia is tested with the Amsler grid and M-charts

    Time frame: before and 3 months after surgery

  2. microscotomata

    New deep microscotomata is tested with microperimetry

    Time frame: before and 3 months after surgery

  3. Thinning of the ganglion cell layer

    Thinning of the ganglion cell layer is assessed with optical coherence tomography

    Time frame: before and 3 months after surgery

  4. Central subfield thickness

    Central subfield thickness of the macula is assessed with optical coherence tomography

    Time frame: before and 3 months after surgery

  5. Best corrected distant visual acuity

    Best corrected distant visual acuity is assessed by EDTRS-charts

    Time frame: before and 3 months after surgery

  6. OCT biomarkers

    OCT biomarkers are assessed by optical coherence tomography

    Time frame: before surgery

07

Study locations

1 site
  • Hanusch Hospital, Department of Ophthalmology
    Vienna, 1140, Austria
08

References and documents

Publications

  • Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology. 1997 Jun;104(6):1033-40. doi: 10.1016/s0161-6420(97)30190-0. PubMed 9186446 ↗
  • Machemer R. [The surgical removal of epiretinal macular membranes (macular puckers) (author's transl)]. Klin Monbl Augenheilkd. 1978 Jul;173(1):36-42. German. PubMed 692034 ↗
  • Leisser C, Palkovits S, Hienert J, Ullrich M, Zwickl H, Georgiev S, Findl O. Effect of Iatrogenic Traction during Macular Peeling Surgery on Postoperative Microperimetry. Ophthalmic Res. 2021;64(2):273-279. doi: 10.1159/000507633. Epub 2020 Apr 1. PubMed 32235121 ↗
  • Leisser C, Hackl C, Hirnschall N, Findl O. Effect of Subfoveal and Extrafoveal Hyporeflective Zones due to Iatrogenic Traction during Membrane Peeling for Epiretinal Membranes on Postoperative Outcomes. Ophthalmologica. 2020;243(4):297-302. doi: 10.1159/000505214. Epub 2019 Dec 5. PubMed 31801147 ↗
  • Diaz RI, Randolph JC, Sigler EJ, Calzada JI. Intraoperative grasp site correlation with morphologic changes in retinal nerve fiber layer after internal limiting membrane peeling. Ophthalmic Surg Lasers Imaging Retina. 2014 Jan-Feb;45(1):45-9. doi: 10.3928/23258160-20131220-06. PubMed 24392911 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06753539
Lead sponsor
Prim. Prof. Dr. Oliver Findl, MBA
Responsible party
Prim. Prof. Dr. Oliver Findl, MBA (Prim. Prof. Dr. Oliver Findl, MBA, Sponsor of the study, Vienna Institute for Research in Ocular Surgery) — Sponsor-investigator
First posted
Dec 31, 2024
Start date
May 12, 2023
Primary completion
Dec 1, 2024
Completion
Dec 1, 2024
Last update
Feb 13, 2025

Study contacts

Christoph Leisser, MD
principal investigator · Mein Hanusch-Krankenhaus

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion